QPS Holdings

QPS Holdings is a contract research organization (CRO) headquartered in Newark, Delaware. Employing over 604 people, QPS generated $235.7 million in revenue. Established in 1995, the company has grown from a small bioanalysis firm to a global CRO with a presence in the United States, Europe, India, and Asia. QPS provides a comprehensive suite of drug development services, encompassing discovery, preclinical, and clinical phases. Their areas of expertise include neuropharmacology, drug metabolism and pharmacokinetics (DMPK), toxicology, bioanalysis, translational medicine, and clinical development. QPS serves pharmaceutical companies requiring high-quality research and development support. QPS differentiates itself through a commitment to quality, technical expertise, and a flexible approach to research. They are recognized for their GLP/GCP compliance, proven quality standards, and dedication to client satisfaction. QPS offers turnkey laboratories and facilities, providing a comprehensive solution for their clients' research needs. For more information, visit qps.com.